Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Chimerix reported $5.68M in Selling and Administration Expenses for its fiscal quarter ending in March of 2023.

Selling And Administration Expenses Change
Ardelyx ARDX:US USD 26.8M 7.07M
Chimerix CMRX:US USD 5.68M 332K
Curis CRIS:US USD 4.76M 430K
Dynavax Technologies DVAX:US USD 36.54M 6.16M
Emergent BioSolutions EBS:US USD 100.5M 6.3M
Gilead Sciences GILD:US USD 1.32B 702M
Glaxosmithkline GSK:US GBP 2.06B 370M
Life Technologies LIFE:US USD 3.41M 18K
Merck & Co MRK:US USD 2.46B 209M
Mirati Therapeutics MRTX:US USD 73.49M 2.67M
Novavax NVAX:US USD 112.53M 49.13M
Xoma XOMA:US USD 6.2M 1.38M